COVID-19: 3 distinct immune responses to SARS-CoV-2 identified
The discovery could help predict the trajectory of disease in severe cases and ultimately inform treatment decisions
Coronavirus update: First death in India
Foreign Minister S Jaishankar said the novel Coronavirus outbreak was “a matter of concern”
Coronavirus Update: Asia’s growth will be lowest since 1967 due to COVID-19, says World Bank
Up to 38 million people in the region will be pushed back into poverty, according to the Bank
Year(s) of the virus: Things we must not forget
The sheer power of the virus, our collective callousness, the sufferings of the working class... there are lessons to be learnt …
Coronavirus outbreak: Bihar increases surveillance across porous Nepal border
A person showing symptoms of carrying the virus was identified at one of the border’s 49 transit points
COVID-19: Should we really bet on hydroxychloroquine
British Medical Journal has questioned the logic of using hydroxychloroquine to treat COVID-19
Coronavirus update: India becomes first country to suspend visas of all foreign nationals
Visas of diplomats, officials, UN / International Organisations officials’ employment visas are exempted
Coronavirus disease: Have experts found a cure yet?
In most cases, doctors administered common drugs like Paracetamol to keep fever under control
COVID-19: Gujarat labourers, tribals forced to take 250 km-long journeys on foot
The workers reportedly began their journey on March 23, 2020, with some accompanied by their wives, children
Coronavirus update: One million kits ordered, says ICMR DG
Centre curtailed entry of Indian passengers travelling from European Union countries, the UK and Turkey, starting from March 18
Pandemic preparedness: Global spending needs 500 years to match COVID-19 rout
New report by WHO arm calls for robust global governance for preparedness to prevent the next pandemic
COVID-19 immunity: Treading turbulent waters
We constantly hear of pills and food supplements that we must consume or lifestyle changes we must inculcate to boost our immune system. …
COVID-19: What the current trend tells us about the next 2 weeks
Near-term prediction and fractal analysis based on current data doesn't show exponential growth
COVID-19 unlockdown is a challenge and an opportunity at the same time
It will generate medium-term challenges but also presents an opportunity to accelerate the shift to more sustainable and equitable growth
COVID-19 pandemic sheds light on urban inequality vs mobility needs in cities
Millions who make the urban ecosystem tick live as squatters, in dense lanes and single rooms
COVID-19: Why the surge in Bihar's cases
Rise in cases in the state puts spotlight on worrying trend of migrant workers reportedly crossing border without telling authorities
Odisha claims lowest rate of COVID-19 cases in the country
Odisha government launches portal for registration of migrant workers who anticipate their return to the state
COVID-19: More than thousand Nepalese migrants stranded in India during harvest time
All the migrants have only one request for authorities in Nepal: To arrange for them an entrance to their home country
COVID-19: Who do you blame a pandemic on?
The role of global economic structures that fomented this pandemic is obscured behind our small indignations
COVID-19: Do Indians have higher immunity to novel coronavirus
Indians have some genetic advantage, but these are still early days to come to any conclusion
COVID-19: UP's Bundelkhand fairs well in lockdown despite reverse migration
Six of seven districts in Uttar Pradesh’s side of the Bundelkhand region implement lockdown successfully
COVID-19: An extreme disorder
Flattening the epidemiological curve also means an economic cessation. Who will bear the burden most in an unequal world?
COVID-19: Livelihood of 1.6 bln informal workers worldwide at risk, warns ILO
Approximately 164 mln informal workers in Africa stuck under complete lockdown measures
Africa must make sure it’s part of the search for a coronavirus vaccine
To refuse inclusion would prevent Africa’s researchers from being significant players in the universal fight against the virus
Phase 1 human trials of Oxford University encouraging: Lancet
The sample size will have to be expanded across demography to check safety and efficacy